bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.01.27.634977

Direct single cell-type gene expression analysis in Whole blood: Novel ratio-based gene expression biomarkers using 2 novel monocyte reference genes (PSAP and CTSS) for monitoring bacterial infection

Abstract

BackgroundTo determine single cell-type specific gene expression in peripheral blood (PB) requires either prior labour-intense cell sorting or expensive single-cell RNA sequencing. We developed and validated a novel ratio-based biomarker (RBB) called Direct Leukocyte Subpopulation-Transcript Abundance (DIRECT LS-TA) assay that allows quantification of monocyte-specific gene expression directly from peripheral blood samples without cell sorting. MethodsThe DIRECT LS-TA method leverages known cell-type proportions and differential gene expression profiles among leukocyte subpopulations (e.g. monocytes, lymphocytes and granulocytes) to identify monocyte-informative genes. We shortlisted genes that had 2.5-fold higher expression in isolated monocytes compared to PB samples, indicating >50% transcript of genes in PB are contributed by monocytes alone. Public gene expression datasets were used to generate a list of monocyte informative genes with which DIRECT LS-TA assay is applicable in PB samples. PSAP and CTSS were identified as the monocyte informative reference genes, based on low biological variation (CV <12%) and high monocyte specificity. They were used as the denominator and together with another monocyte informative target gene as the numerator, the value of this new DIRECT LS-TA can be determined which is a kind of ratio-based biomarker (RBB). The clinical utility was the differentiation of patients with bacterial infection from control subjects in a discovery dataset and 4 other replication datasets. Methods to convert DIRECT LS-TA results to multiple of control median (MoM) provided approximations to delta-delta CT values of relative quantification commonly used in qPCR or digital PCR assays. ResultsOver 50 monocyte-informative genes were identified, including key immune response genes like IFI44L, IL1B, VNN1 and NFKBIZ. DIRECT LS-TA results showed excellent correlation with the gold standard results, gene expression in isolated monocyte expression (R2=0.55-0.97). Then, DIRECT LS-TA of these 50 target genes were evaluated to identify the best RBB to detect the host response to bacterial infection. Monocyte DIRECT LS-TA VNN1 RBB showed consistent upregulation across five independent datasets (median fold change 2.7-fold, p<10-8) with strong diagnostic performance (AUC=0.84-0.99). The expected corresponding delta-delta CT value is more than 1.4 cycle which can be reliably measured by qPCR. Additional monocyte-informative genes including NLRC4, CYP1B1, PFKFB3, LILRA5, NFKBIA, and NFKBIZ also demonstrated significant diagnostic ability (AUC>0.8). ConclusionsThe DIRECT LS-TA method (as a simple RBB) provides reliable quantification of monocyte-specific gene expression directly from whole blood samples without cell separation. The robust performance in bacterial infection diagnosis demonstrates its potential clinical utility for rapid infection differentiation and informed antibiotic stewardship. DIRECT LS-TA will emerge as a new kind of in vitro diagnostics (IVD) which can convey single cell-type gene expression information from PB samples. The new kind of IVD and uniqueness of the information, together with the ease of implementation will make it very useful in clinics

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tang, N. L.-s., Kwan, T.-K., Huang, D., Ma, S. L., Leung, K.-S.. 2025-01-28. Direct single cell-type gene expression analysis in Whole blood: Novel ratio-based gene expression biomarkers using 2 novel monocyte reference genes (PSAP and CTSS) for monitoring bacterial infection. https://doi.org/10.1101/2025.01.27.634977

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

TFAM Dependent Mitochondrial Fitness Limits CD8⁺ T Cell Immunopathology and Sustains Protective Immunity during Viral Pneumonia

During respiratory virus infection, CD8 T cells kill infected cells and establish antigen-specific memory, but mechanisms regulating these functions remain incompletely understood. Here, we identify mitochondrial transcription factor A (TFAM)-dependent mitochondrial fitness as a regulator of CD8 T cell function during influenza infection. Human CD8 T cells exhibited an age-associated decline in TFAM expression and mitochondrial function. To model this physiologically relevant decline and determine its consequences for antiviral immunity, we generated CD8 T cell-specific TFAM-haploinsufficient mice. TFAM insufficiency disrupted mitochondrial integrity and bioenergetics and increased mitochondrial DNA and oxidative stress. During influenza infection, TFAM-insufficient CD8 T cells exhibited increased cytotoxic and inflammatory activity associated with lung immunopathology without improved viral control. This early phenotype was followed by loss of effector function, diminished antigen-specific responses, reduced protection following adoptive transfer, and impaired heterosubtypic recall immunity. Thus, TFAM-dependent mitochondrial fitness is a cell-intrinsic regulator that limits immunopathology while sustaining recall immunity.

immunology↗

Gasdermin E couples mitochondrial stress to STING-driven neuronal pyroptosis during Chandipura virus encephalitis

Neurotropic RNA viruses are major causes of fatal encephalitis worldwide, yet how infected neurons transition from antiviral defense to inflammatory cell death is not well characterized. Chandipura virus (CHPV), an emerging neurotropic rhabdovirus, causes acute, rapidly progressive encephalitis with high case fatality in children, but the mechanisms underlying its neuropathogenesis remain poorly defined. Here, we demonstrate that CHPV suppresses canonical RNA virus sensing early but subsequently switches to a mitochondria-driven innate immune program that culminates in inflammatory cell death. Early infection of neuronal cells with CHPV was marked by reduced levels of the mitochondrial antiviral adaptor protein, MAVS and attenuation of type I and III interferon responses. As infection progressed, mitochondrial dysfunction promoted accumulation of mtROS, mitochondrial accumulation of cleaved GSDME and cytosolic mtDNA release, triggering STING activation, which coincided with robust neuroinflammation and pyroptotic cell death. Pharmacological inhibition or genetic silencing of STING markedly attenuated inflammatory signaling, prevented pyroptotic membrane rupture and protected neurons from cell death without significantly affecting viral replication. In contrast, GSDME depletion reduced both viral replication and neuronal death. Notably, GSDME depletion markedly attenuated STING phosphorylation, while STING depletion also reduced GSDME activation, revealing functional coupling between these pathways during CHPV-induced neuronal injury. Collectively, our findings identify a mitochondria-GSDME-STING axis linking early immune evasion to neuroinflammation during CHPV infection, revealing a previously unrecognized mechanism of inflammatory neuronal death in viral encephalitis and highlighting STING as a potential therapeutic target in certain CNS viral infections.

immunology↗

Mutanome-guided immunopeptidomics of blood plasma for neoepitope detection in solid tumors is constrained by cfDNA variant calling sensitivity and MS detection limits

Introduction: Neoepitopes form the basis of tumor-specific immune responses. Tissue biopsy, the primary source for neoepitope detection, is limited and invasive. Therefore, we aimed to identify neoepitopes by mutanome-guided immunopeptidomics from plasma of cancer patients. Methods: Mass spectrometry (MS) data analysis of HLA ligands from plasma (n = 4) was guided by patient-specific mutanomes of cell-free DNA (cfDNA) from plasma or tumor genomic DNA (tgDNA) from tissue. Matched tumor tissue and healthy donor plasma served as controls. Neoepitopes were validated with synthetic peptides, and immunogenicity was assessed using IFN-gamma ELISpot and intracellular cytokine staining. Results: Wild-type immunopeptidomes from tissue and plasma overlapped by 58%, with 91% of plasma HLA ligands rediscovered in tissue. 13 out of 15 tumor-associated HLA ligands detected in plasma were rediscovered in the matching tissue. However, no neoepitopes in plasma were identified by immunopeptidomics guided by cfDNA mutanomes, likely reflecting the limited overlap between cfDNA and tgDNA mutanomes (15%). Using the tgDNA mutanome as a complementary reference, two neoepitopes were detected in one patient's plasma, albeit at the MS detection limit. Both neoepitopes were also discovered in tissue, along with three tissue-exclusive neoepitopes. Two tissue-exclusive neoepitopes induced antigen-specific T cell responses in healthy donor PBMCs. Conclusion: In summary, plasma immunopeptidomics enables profiling of HLA ligands from wild-type proteins, including TAAs. In principle, neoepitope detection from plasma at the peptide level is feasible, but tissue remains the gold standard for variant calling and neoepitope identification. Improved detection methods may enable minimally invasive approaches in the future.

immunology↗